Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Repligen
3158
Repligen
Technology
Biotechnology
Life Sciences
Nearly all therapeutic monoclonal antibodies (mAbs) on the market or in development are produced using bioprocessing products manufactured by Repligen
Suggest edits
Type
B2c
Founded
1981
Raised
$4M
Follow us
Companies in the same industry
PATHSENSORS
TELA Bio
Tango Therapeutics
Green Goods Invest
Asimov
Chinook Therapeutics
Ozette
Genohm
Helicos BioSciences
C4X Discovery Ltd
Alexa global traffic share
Twitter followers
Overview
Funding
1
Acquisitions
1
Add info
Latest funding
$4,000,000
Venture capital - 2014
Team Size
50+
Employees
I work here
Location
United States
Headquarters
Explore United States
The Motley Fool
Read This Before You Sell Repligen Corporation Stock
The Motley Fool
Repligen Corporation Jumped 14.6% in February -- Here's Why
The Motley Fool
Why Repligen Corporation Shares Are Falling --
